Aurobindo Aims For Europe Growth With Apotex Acquisitions
The Indian drug maker is handing over €74m to Canada's Apotex, buying the latter's operations in Poland, the Czech Republic, the Netherlands, Spain and Belgium and adding over 200 generics and more than 80 OTC products to its portfolio.
You may also be interested in...
A share purchase agreement for the sale of Zentiva has been signed with private equity group Advent, so Sanofi can concentrate on making the most of its new acquisitions.
Strides Shasun founder Arun Kumar has moved back into the driver’s seat to focus on “course correction” after the Indian drug maker racked up an unexpected quarterly loss that triggered a massive share selloff.
India’s Aurobindo Pharma has catapulted to the top spot in the Portuguese generic market with the buyout of Generis Farmacêutica SA and hopes to cash in on its extensive portfolio and brand loyalty to drive growth.